BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 29627724)

  • 21. Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer.
    Hodgkinson N; Kruger CA; Mokwena M; Abrahamse H
    J Photochem Photobiol B; 2017 Dec; 177():32-38. PubMed ID: 29045918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.
    Wan DH; Zheng BY; Ke MR; Duan JY; Zheng YQ; Yeh CK; Huang JD
    Chem Commun (Camb); 2017 Apr; 53(29):4112-4115. PubMed ID: 28349131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
    Broekgaarden M; Weijer R; van Wijk AC; Cox RC; Egmond MR; Hoebe R; van Gulik TM; Heger M
    J Biomed Nanotechnol; 2017 Feb; 13(2):204-20. PubMed ID: 29377650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications.
    Lopez T; Ortiz E; Alvarez M; Navarrete J; Odriozola JA; Martinez-Ortega F; Páez-Mozo EA; Escobar P; Espinoza KA; Rivero IA
    Nanomedicine; 2010 Dec; 6(6):777-85. PubMed ID: 20493967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Huang Z; Xiao H; Lu X; Yan W; Ji Z
    Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoscale Metal-Organic Layer Isolates Phthalocyanines for Efficient Mitochondria-Targeted Photodynamic Therapy.
    Nash GT; Luo T; Lan G; Ni K; Kaufmann M; Lin W
    J Am Chem Soc; 2021 Feb; 143(5):2194-2199. PubMed ID: 33528255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid-triggered controlled release and fluorescence-switchable phthalocyanine nanoassemblies combined with O
    Liu X; Chen L; Chen Z
    Bioorg Chem; 2024 Feb; 143():106986. PubMed ID: 37995641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy.
    Liu J; Kang DW; Fan Y; Nash GT; Jiang X; Weichselbaum RR; Lin W
    J Am Chem Soc; 2024 Jan; 146(1):849-857. PubMed ID: 38134050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.
    Chen Z; Zhou S; Chen J; Deng Y; Luo Z; Chen H; Hamblin MR; Huang M
    ChemMedChem; 2010 Jun; 5(6):890-8. PubMed ID: 20458713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phthalocyanine-Conjugated Glyconanoparticles for Chemo-photodynamic Combination Therapy.
    Dag A; Cakilkaya E; Omurtag Ozgen PS; Atasoy S; Yigit Erdem G; Cetin B; Çavuş Kokuroǧlu A; Gürek AG
    Biomacromolecules; 2021 Apr; 22(4):1555-1567. PubMed ID: 33793222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma.
    Yu W; Ye M; Zhu J; Wang Y; Liang C; Tang J; Tao H; Shen Y
    Nanomedicine; 2018 Jun; 14(4):1099-1110. PubMed ID: 29462663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
    Kuzyniak W; Ermilov EA; Atilla D; Gürek AG; Nitzsche B; Derkow K; Hoffmann B; Steinemann G; Ahsen V; Höpfner M
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():148-157. PubMed ID: 26162500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monomer zinc phthalocyanine/upconversion nanoparticle coated with hyaluronic acid crosslinked gel as NIR light-activated drug for in vitro photodynamic therapy.
    Zhou L; Chen E; Jin W; Wang Y; Zhou J; Wei S
    Dalton Trans; 2016 Sep; 45(38):15170-15179. PubMed ID: 27711660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upconverting crystal/dextran-g-DOPE with high fluorescence stability for simultaneous photodynamic therapy and cell imaging.
    Wang H; Wang S; Liu Z; Dong C; Yang J; Gong X; Chang J
    Nanotechnology; 2014 Apr; 25(15):155103. PubMed ID: 24651122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pH-sensitive micelle composed of heparin, phospholipids, and histidine as the carrier of photosensitizers: Application to enhance photodynamic therapy of cancer.
    Debele TA; Mekuria SL; Tsai HC
    Int J Biol Macromol; 2017 May; 98():125-138. PubMed ID: 28137464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of photodynamic activity, photostability and in vitro drug release of zinc phthalocyanine-loaded nanocapsules.
    de Souza TD; Ziembowicz FI; Müller DF; Lauermann SC; Kloster CL; Santos RC; Lopes LQ; Ourique AF; Machado G; Villetti MA
    Eur J Pharm Sci; 2016 Feb; 83():88-98. PubMed ID: 26678154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of in vitro PDT activities of zinc phthalocyanine immobilised TiO
    Yurt F; Ince M; Colak SG; Ocakoglu K; Er O; Soylu HM; Gunduz C; Avci CB; Kurt CC
    Int J Pharm; 2017 May; 524(1-2):467-474. PubMed ID: 28365390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
    Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A light-triggered self-reinforced nanoagent for targeted chemo-photodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways.
    Huang Y; Xiao Z; Guan Z; Shen Y; Jiang Y; Xu X; Huang Z; Zhao C
    J Control Release; 2020 Mar; 319():119-134. PubMed ID: 31883459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
    Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
    Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.